Sunday, April 26, 2026
Subscribe

Singaporean biotech company Nuevocor bags $45m collection B

by


Nuevocor’s LMNA DCM is a hereditary condition that impacts greater than 100,000 individuals in these locations.

Post Views: 96

Tags

Related Posts

The Tamesis

Leave a Reply

Your email address will not be published.

Previous Story

Singapore’s Huge Flight terminal Job Presses Onward With $3.7 Billion Dealings Granted

Next Story

Digital doubles in health care market to strike $59.94 b by 2030 

Latest from Blog

Related Posts

Previous Story

Singapore’s Huge Flight terminal Job Presses Onward With $3.7 Billion Dealings Granted

Next Story

Digital doubles in health care market to strike $59.94 b by 2030 

Don't Miss

10 Best Peptide Eye Creams to Lift, Firm, and Hydrate

You’ve heard the basics: Peptides are

China AI Circuit Board Firm Raises $2bn in Year’s Top HK Listing

A Chinese technology company that supplies